GO:0072051 juxtaglomerular apparatus development: Homeostatic Blood Pressure Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0072051 describes the developmental process by which the juxtaglomerular apparatus (JGA) forms and matures into a structure that regulates kidney function.
• The JGA is a specialized anatomical unit positioned adjacent to the glomerulus and is central to renin-angiotensin system (RAS) control of blood pressure and fluid balance.
• Renin-producing juxtaglomerular cells exhibit phenotypic plasticity, meaning they can switch between contractile and endocrine phenotypes during development and disease.
• Postnatal maturation of the JGA has been documented in rodent models, showing progressive structural and functional specialization after birth.
• Disruption of JGA development or function is linked to hypertension, chronic kidney disease, hypoaldosteronism, and diabetic blood pressure dysregulation.
• Modern CRISPR-based models (knockout, knock-in, overexpression) enable causal dissection of genes controlling JGA development and renin cell identity.
Description
The juxtaglomerular apparatus (JGA) is a specialized anatomical structure that lies adjacent to the glomerulus and regulates kidney function. The Gene Ontology term GO:0072051, juxtaglomerular apparatus development, refers to the process whose specific outcome is the progression of the JGA over time, from its formation to the mature structure. Understanding this developmental process is essential because the JGA is the principal site of renin synthesis and release, and therefore a master regulator of the renin-angiotensin system (RAS), blood pressure, and electrolyte homeostasis. Research over several decades has established that the JGA is not a static structure but a dynamic, plastic unit. Juxtaglomerular cells can undergo phenotypic switching between contractile smooth-muscle-like states and endocrine renin-secreting states, a plasticity that is critical during development and in response to physiological stress. Postnatal studies in rats have shown that the JGA continues to mature after birth, with progressive changes in cell number, granule content, and innervation. For researchers, GO:0072051 provides a structured framework to annotate genes and pathways that control JGA formation, maturation, and function. Because JGA dysfunction is implicated in chronic kidney disease, hypertension, hypoaldosteronism, and diabetes-associated blood pressure dysregulation, the genes and mechanisms underlying this developmental process are attractive targets for both mechanistic studies and therapeutic development.
juxtaglomerular apparatus development At A Glance
| GO ID | GO:0072051 |
|---|---|
| GO term | juxtaglomerular apparatus development |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Major function | Formation and maturation of the juxtaglomerular apparatus, which regulates kidney function and blood pressure via the renin-angiotensin system |
| Anatomical context | Structure adjacent to the glomerulus, integrating tubular and vascular signals |
| Key cell type | Renin-producing juxtaglomerular cells with phenotypic plasticity |
| Related physiology | Tubuloglomerular feedback, renin secretion, aldosterone regulation |
| Disease relevance | Hypertension, chronic kidney disease, hypoaldosteronism, diabetic blood pressure dysregulation |
What Is GO:0072051?
GO:0072051, juxtaglomerular apparatus development, is a biological process defined as the progression of the juxtaglomerular apparatus over time, from its formation to the mature structure. The juxtaglomerular apparatus is an anatomical structure that lies adjacent to the glomerulus and regulates kidney function. In practical terms, this term captures all cellular and molecular events that build, organize, and mature the JGA, including the specification and differentiation of juxtaglomerular cells, their acquisition of renin-producing capacity, and the establishment of the structural relationship with the glomerulus and distal tubule that enables tubuloglomerular feedback and RAS control.
Why Is juxtaglomerular apparatus development Important in Cell Biology?
GO:0072051 is important because the juxtaglomerular apparatus is the central control node for the renin-angiotensin system, and its development determines the kidney's lifelong capacity to regulate blood pressure, fluid volume, and electrolyte balance. Defects in JGA formation or maturation can lead to impaired renin secretion, hypoaldosteronism, and abnormal blood pressure control. Moreover, the plasticity of juxtaglomerular cells means that developmental programs can be reactivated in disease states, contributing to hypertension and chronic kidney disease progression. Studying this term therefore bridges developmental biology, renal physiology, and clinical nephrology.
• The JGA is the primary source of renin and thus a master regulator of the renin-angiotensin system.
• JGA development determines the structural basis for tubuloglomerular feedback and glomerular hemodynamic control.
• Juxtaglomerular cell phenotypic plasticity links developmental mechanisms to adult disease.
• Impaired JGA function is associated with hypoaldosteronism and electrolyte disorders.
• Chronic kidney disease involves maladaptive JGA-mediated homeostatic mechanisms.
• Diabetes and hypertension share pathophysiological links that converge on JGA and RAS regulation.
• Postnatal JGA maturation is a dynamic process that can be studied in rodent models.
• Genes controlling JGA development are candidate targets for antihypertensive and renoprotective therapies.
• CRISPR-based models allow causal testing of JGA developmental genes in vivo and in vitro.
• Understanding JGA development aids interpretation of single-cell and spatial transcriptomic kidney atlases.
What Happens During juxtaglomerular apparatus development?
Specification of renin cell lineage
In simple terms: Early in kidney development, certain cells are instructed to become the renin-producing cells of the JGA.
The first stage of JGA development involves the specification of a renin-expressing cell lineage from progenitors in the developing kidney. These cells are characterized by the expression of renin and are the precursors of the mature juxtaglomerular cells. Lineage-tracing studies have shown that renin cells are derived from a subset of mesenchymal progenitors that also contribute to other renal cell types, and that their specification depends on a combination of transcriptional and signaling cues. This stage establishes the endocrine identity of the future JGA.
Formation of the juxtaglomerular cell cluster
In simple terms: The renin-producing cells gather at the vascular pole of the glomerulus to form a distinct cluster.
As development proceeds, renin-expressing cells migrate to and cluster at the vascular pole of the glomerulus, where they will form the juxtaglomerular apparatus. This clustering is accompanied by the acquisition of a more differentiated phenotype, including the accumulation of renin-containing granules. The cells also establish close contact with the afferent arteriole and the distal tubule, forming the anatomical triad that defines the JGA. This stage is critical for the future functional integration of the JGA.
Maturation of the JGA and tubuloglomerular feedback
In simple terms: The JGA matures so it can sense salt levels in the distal tubule and adjust blood flow and renin release accordingly.
Maturation of the JGA involves the functional integration of its components, including the macula densa, extraglomerular mesangium, and juxtaglomerular cells. The macula densa senses NaCl concentration in the distal tubule and signals to juxtaglomerular cells to regulate renin release and afferent arteriolar tone, a process known as tubuloglomerular feedback. Postnatal studies in rats have documented progressive changes in JGA morphology and granule content after birth, indicating that maturation continues into the postnatal period. This stage ensures that the JGA can maintain blood pressure and fluid balance throughout life.
Phenotypic plasticity and maintenance
In simple terms: Even after development, JGA cells can change their identity in response to stress, which is important for adaptation but can also contribute to disease.
Juxtaglomerular cells retain a remarkable phenotypic plasticity throughout life. Under conditions of physiological stress, such as dehydration or hypotension, they can switch between a contractile, smooth-muscle-like phenotype and an endocrine, renin-secreting phenotype. This plasticity is thought to recapitulate developmental programs and is mediated by transcriptional and epigenetic mechanisms. While adaptive in the short term, sustained activation of these programs can contribute to hypertension and chronic kidney disease progression. Understanding this stage is therefore essential for linking JGA development to adult disease.
Key Genes Involved in GO:0072051 juxtaglomerular apparatus development
The following genes and proteins have been implicated in the development, maturation, and function of the juxtaglomerular apparatus based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| REN | Encodes renin, the rate-limiting enzyme of the renin-angiotensin system and the hallmark of juxtaglomerular cells | Central marker of JGA development and function; target for hypertension research |
| AGT | Encodes angiotensinogen, the substrate for renin | Key component of the RAS cascade; relevant to JGA-mediated blood pressure control |
| ACE | Encodes angiotensin-converting enzyme, which generates angiotensin II | Modulates JGA function and blood pressure; target of antihypertensive drugs |
| AGTR1 | Encodes angiotensin II receptor type 1, mediating feedback on renin release | Important for tubuloglomerular feedback and JGA homeostasis |
| TRPM3 | TRPM3 channels regulate blood pressure via tubuloglomerular feedback and plasma volume control | Novel player in JGA-mediated blood pressure regulation; potential therapeutic target |
| NOTCH1 | Notch signaling is involved in renal development and may influence JGA formation | Candidate pathway for JGA developmental studies |
| WT1 | Wilms tumor 1 is a transcription factor important for kidney development | May regulate renin cell lineage specification |
| FOXD1 | Transcription factor marking renal stromal progenitors that contribute to JGA | Lineage tracing and developmental studies |
| PDGFRB | Platelet-derived growth factor receptor beta marks mesangial and related cells | Potential marker for JGA-associated mesangial cells |
| ACTA2 | Encodes smooth muscle actin, marking the contractile phenotype of juxtaglomerular cells | Used to assess phenotypic plasticity of JGA cells |
| CD34 | Marker of hematopoietic and endothelial progenitors, sometimes used in kidney studies | May help identify progenitor populations in JGA development |
| COL1A1 | Collagen type I alpha 1, component of extracellular matrix in the JGA region | Relevant to structural maturation of the JGA |
| NOS1 | Neuronal nitric oxide synthase, expressed in macula densa and involved in tubuloglomerular feedback | Modulates JGA signaling and renin release |
| SLC12A1 | NKCC2 cotransporter in macula densa, essential for sensing tubular NaCl | Key for tubuloglomerular feedback and JGA function |
| KCNJ1 | ROMK potassium channel in macula densa, contributes to salt sensing | Relevant to JGA-mediated feedback |
| AGTR2 | Angiotensin II receptor type 2, may counterbalance AGTR1 effects | Potential modulator of JGA development and function |
| CYP11B2 | Aldosterone synthase, downstream of JGA-mediated RAS activation | Links JGA development to adrenal aldosterone production |
| NR3C2 | Mineralocorticoid receptor, mediates aldosterone effects | Relevant to hypoaldosteronism and JGA-related disorders |
How Is juxtaglomerular apparatus development Regulated?
The development and function of the juxtaglomerular apparatus are regulated by multiple intersecting mechanisms. The renin-angiotensin system itself provides negative feedback: angiotensin II acting via AGTR1 suppresses renin release from juxtaglomerular cells. Tubuloglomerular feedback, mediated by macula densa sensing of NaCl via SLC12A1 and KCNJ1, adjusts afferent arteriolar tone and renin secretion. TRPM3 channels have been shown to regulate blood pressure via tubuloglomerular feedback and plasma volume control, adding another layer of regulation. Transcriptional and epigenetic programs control the phenotypic plasticity of juxtaglomerular cells, allowing them to switch between contractile and endocrine states. Additionally, systemic factors such as blood pressure, volume status, and aldosterone influence JGA function through both direct and indirect pathways.
juxtaglomerular apparatus development and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| REN | Hypertension, chronic kidney disease, hypoaldosteronism | Ren knockout or point-mutation mouse models; renin reporter knock-in |
| AGTR1 | Hypertension, cardiovascular disease | Agtr1 knockout and conditional knock-in models |
| TRPM3 | Blood pressure regulation via tubuloglomerular feedback | Trpm3 knockout mice; overexpression models |
| ACE | Hypertension, diabetic nephropathy | Ace knockout and point-mutation models |
| CYP11B2 | Hypoaldosteronism, electrolyte disorders | Cyp11b2 knockout and knock-in models |
Hypertension and chronic kidney disease
Dysregulation of the juxtaglomerular apparatus and the renin-angiotensin system is a central mechanism in hypertension and chronic kidney disease. JGA-mediated homeostatic mechanisms, when maladaptive, contribute to progressive kidney injury and elevated blood pressure. Renin cells and their plasticity have been directly implicated in hypertension pathogenesis, as inappropriate renin secretion or cell fate changes can sustain elevated blood pressure. Targeting JGA-related pathways is therefore a therapeutic strategy in chronic kidney disease.
Hypoaldosteronism and electrolyte disorders
Hypoaldosteronism can result from impaired renin secretion or JGA dysfunction, leading to hyperkalemia and metabolic acidosis. Because aldosterone synthesis in the adrenal gland is driven by angiotensin II generated through the RAS, defects in JGA development or function can manifest as secondary hypoaldosteronism. Understanding JGA development helps clarify the developmental origins of these electrolyte disorders.
Diabetes and blood pressure dysregulation
Diabetes and hypertension share pathophysiological links that involve the JGA and RAS. Hyperglycemia and insulin resistance can alter JGA function and renin release, contributing to blood pressure dysregulation in diabetic patients. The interplay between diabetes and JGA-mediated blood pressure control is an active area of research, with implications for therapeutic targeting.
Renal developmental disorders
Because the JGA forms during kidney development, disruptions in developmental programs can lead to structural and functional renal abnormalities. Postnatal maturation studies in rats have shown that the JGA continues to develop after birth, suggesting that perinatal insults could affect its final structure and function. Genes controlling renin cell lineage specification are candidate contributors to developmental kidney disorders.
From juxtaglomerular apparatus development-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X control renin cell specification? | Knockout mouse or human iPSC-derived kidney organoids with CRISPR knockout |
| Does a specific point mutation in REN alter JGA development? | Point-mutation knock-in mouse or isogenic iPSC lines |
| Can we track JGA cell lineage in vivo? | Tagged knock-in reporter (e.g., REN-GFP) mouse or organoid |
| Does overexpression of gene Y expand renin cell population? | Overexpression transgenic or viral delivery models |
| How does TRPM3 modulate tubuloglomerular feedback? | Trpm3 knockout and overexpression models with physiological measurements |
| What transcriptional networks regulate JGA maturation? | CRISPR library screening in kidney organoids followed by single-cell RNA-seq |
How to Study the juxtaglomerular apparatus development Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-cell RNA-seq | Transcriptomes of individual JGA cells | Identifying renin cell subtypes and developmental trajectories |
| Spatial transcriptomics | Gene expression with spatial context | Mapping JGA structure in developing kidney |
| Lineage tracing | Origin and fate of renin cell progenitors | Tracking JGA development in vivo |
| Telemetric blood pressure monitoring | Blood pressure in conscious animals | Assessing JGA function in knockout models |
| Tubuloglomerular feedback assay | Afferent arteriolar response to NaCl | Evaluating macula densa signaling |
| Immunohistochemistry | Protein localization and abundance | Characterizing JGA morphology and maturation |
| Electron microscopy | Ultrastructure of JGA cells and granules | Studying postnatal JGA development |
| CRISPR library screening | Gene function at scale | Discovering novel regulators of JGA development |
Single-cell and spatial transcriptomics
Single-cell RNA sequencing and spatial transcriptomics allow researchers to map the cellular composition of the developing JGA and identify transcriptional programs specific to renin cells and their neighbors. These methods can reveal rare progenitor populations and track their differentiation trajectories over developmental time.
Lineage tracing and reporter models
Genetic lineage tracing using Cre-lox or fluorescent reporters (e.g., REN-GFP) enables visualization of renin cell specification, migration, and maturation in vivo. These models are essential for understanding the developmental origin of juxtaglomerular cells and their plasticity.
Physiological measurements of JGA function
Techniques such as micropuncture, tubuloglomerular feedback assays, and telemetric blood pressure monitoring in knockout models allow functional assessment of the JGA. These methods link developmental gene function to physiological outcomes such as renin release and vascular tone.
Histology and electron microscopy
Classical histology, immunohistochemistry, and electron microscopy have been used to characterize the postnatal development of the JGA, including granule formation and innervation. These methods remain valuable for validating findings from molecular studies.
How CRISPR Can Be Used to Study GO:0072051 juxtaglomerular apparatus development
Knockout
CRISPR knockout models are used to test the causal role of candidate genes in JGA development. For example, knocking out REN or AGTR1 in mice or human kidney organoids can reveal their requirement for renin cell specification and JGA maturation. Knockout studies of TRPM3 have demonstrated its role in blood pressure regulation via tubuloglomerular feedback.
Point Mutation
Point-mutation knock-in models allow precise testing of disease-associated variants in genes such as REN or AGTR1. These models can reveal how specific amino acid changes affect renin secretion, JGA development, and blood pressure regulation. Isogenic iPSC lines with point mutations are valuable for studying human-specific effects.
Knock-in
Knock-in of reporter genes (e.g., GFP or luciferase) into the REN locus enables real-time tracking of renin cell development and plasticity. Tagged knock-in models also facilitate biochemical studies of renin processing and secretion. These models are essential for lineage tracing and dynamic studies of JGA development.
Overexpression
Overexpression models, such as transgenic mice or viral delivery, are used to test whether increased levels of a gene product expand or alter the JGA. For example, overexpression of renin or angiotensinogen can lead to hypertension and JGA remodeling. These models complement knockout studies by providing gain-of-function evidence.
How EDITGENE Supports juxtaglomerular apparatus development Research
Researchers studying juxtaglomerular apparatus development-related genes often need to determine whether a candidate gene is causally involved in JGA formation, maturation, or function. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell and animal models, enabling rigorous functional validation of genes implicated in GO:0072051.
Contact EDITGENE today to design your custom CRISPR model for juxtaglomerular apparatus development research.
Frequently Asked Questions About juxtaglomerular apparatus development
What is GO:0072051?
GO:0072051 is the Gene Ontology term for juxtaglomerular apparatus development, the biological process by which the juxtaglomerular apparatus forms and matures to regulate kidney function.
What is the juxtaglomerular apparatus?
The juxtaglomerular apparatus is an anatomical structure adjacent to the glomerulus that regulates kidney function, primarily through renin secretion and the renin-angiotensin system.
What genes are involved in juxtaglomerular apparatus development?
Key genes include REN, AGT, ACE, AGTR1, TRPM3, and transcription factors such as WT1 and FOXD1, based on published literature.
Why is juxtaglomerular apparatus development important?
It determines the kidney's capacity to regulate blood pressure, fluid balance, and electrolytes via the renin-angiotensin system, and its dysfunction is linked to hypertension and chronic kidney disease.
How is the juxtaglomerular apparatus studied?
Researchers use single-cell RNA-seq, lineage tracing, knockout models, physiological measurements, and histology to study JGA development and function.
What diseases are associated with JGA dysfunction?
Hypertension, chronic kidney disease, hypoaldosteronism, and diabetes-associated blood pressure dysregulation are associated with JGA dysfunction.
What is the role of renin in the JGA?
Renin is the rate-limiting enzyme of the renin-angiotensin system and is produced by juxtaglomerular cells; its release controls angiotensin II generation and blood pressure.
Can CRISPR be used to study JGA development?
Yes, CRISPR knockout, knock-in, and overexpression models in mice and human organoids enable causal testing of genes involved in JGA development.
What is tubuloglomerular feedback?
Tubuloglomerular feedback is a mechanism by which the macula densa senses NaCl in the distal tubule and signals to the afferent arteriole and juxtaglomerular cells to regulate renin release and vascular tone.
What is juxtaglomerular cell phenotypic plasticity?
It is the ability of juxtaglomerular cells to switch between contractile and endocrine (renin-secreting) phenotypes in response to physiological stress, a process linked to development and disease.
Conclusion
GO:0072051, juxtaglomerular apparatus development, is a fundamental biological process that underpins the kidney's ability to regulate blood pressure and fluid homeostasis through the renin-angiotensin system. The JGA is a dynamic structure whose development involves the specification, clustering, and maturation of renin-producing cells, followed by lifelong phenotypic plasticity. Disruption of these processes is implicated in hypertension, chronic kidney disease, hypoaldosteronism, and diabetic blood pressure dysregulation. Advances in CRISPR-based models, single-cell genomics, and physiological assays are accelerating the discovery of genes and mechanisms controlling JGA development. EDITGENE's suite of knockout, point-mutation, knock-in, overexpression, and library screening services provides researchers with the tools needed to causally validate candidate genes and translate findings into therapeutic strategies for JGA-related diseases.
References
- 1. Higashihara E et al.. 2024. Juxtaglomerular apparatus-mediated homeostatic mechanisms: therapeutic implication for chronic kidney disease.. Expert Opin Pharmacother 25(7):819-832 PMID: 38773961
- 2. Polycarpe C et al.. 2026. Hypoaldosteronism.. PMID: 32310452
- 3. Martini AG et al.. 2017. Juxtaglomerular Cell Phenotypic Plasticity.. High Blood Press Cardiovasc Prev 24(3):231-242 PMID: 28527017
- 4. Ichihara A et al.. 2004. Renal renin-angiotensin system.. Contrib Nephrol 143:117-30 PMID: 15248360
- 5. Sequeira-Lopez MLS et al.. 2021. Renin Cells, the Kidney, and Hypertension.. Circ Res 128(7):887-907 PMID: 33793334
- 6. Vesna L et al.. 1980. Postnatal development of the kidney juxtaglomerular apparatus in rats.. Acta Anat (Basel) 108(3):281-7 PMID: 7415794
- 7. Rojo-Mencia J et al.. 2025. Renal TRPM3 Channels Regulate Blood Pressure via Tubuloglomerular Feedback and Plasma Volume Control.. Hypertension 82(12):2085-2097 PMID: 41031400
- 8. Libianto R et al.. 2018. Pathophysiological Links Between Diabetes and Blood Pressure.. Can J Cardiol 34(5):585-594 PMID: 29731021
